Healthcare Stocks

Abbott (ABT), Anthem (ANTM) stocks rise after upbeat revenue outlook

 Abbott (ABT), Anthem (ANTM) stocks rise after upbeat revenue outlook

Highlights Abbott Laboratories’ (NYSE: ABT) third-quarter sales rose 23.4% to US$10.9 billion YoY. Abbott raised its full-year adjusted EPS guidance to between US$5.00 and US$5.10. Anthem, Inc’s (NYSE: ANTM) operating revenue jump...

Read More...
Walgreens Boots (WBA) profits up 6.4% in Q4 as sales surge

Walgreens Boots (WBA) profits up 6.4% in Q4 as sales surge

Pharmacy chain operator Walgreens Boots Alliance Reports on Thursday reported a fourth-quarter profit of US$358 million after witnessing robust growth in the US and the UK markets. Walgreens’ net earnings from operations increased by 6.4% Yo...

Read More...
UnitedHealth (UNH) raises guidance on strong Q3 growth, revenue up 11%

UnitedHealth (UNH) raises guidance on strong Q3 growth, revenue up 11%

Highlights UnitedHealth Group (NYSE: UNH) declared third-quarter results on Thursday. The group served 146 million people across its businesses as of September 30, 2021. UNH posted revenue of US$72.3 billion and 23.5% return on equity in the t...

Read More...
Nutriband (NTRB), Protara (TARA) stocks gallop on deals, drug approval

Nutriband (NTRB), Protara (TARA) stocks gallop on deals, drug approval

Highlights Nutriband Inc. (NASDAQ: NTRB) stock jumped on securing a lucrative manufacturing deal with San Diego-based Diomics for its Diocheck™ technology. Protara Therapeutics, Inc. (NASDAQ: TARA) climbed 11.41% after receiving FDA clear...

Read More...
CLOV, ADMS stocks up on rating upgrade, purchase deal

CLOV, ADMS stocks up on rating upgrade, purchase deal

Highlights Stocks of Clover Health Investments, Corp. (NASDAQ: CLOV) and Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) were gaining traction on Monday. The Centers for Medicare and Medicaid Services (CMS) upgraded the CLOV stock to a 3.5-star rat...

Read More...
ChemoCentryx (CCXI), Vaxart (VXRT) stocks rally on upbeat drug news

ChemoCentryx (CCXI), Vaxart (VXRT) stocks rally on upbeat drug news

Highlights FDA has approved ChemoCentryx's drug Avacopan, to be sold under the brand name Tavneos. A Duke University study showed Vaxart's oral drug is more effective in reducing SARS-CoV-2 transmission.  Vaxart, Inc. (NASDAQ: VXRT) stock...

Read More...
Voyager Therapeutics (VYGR) stock jumps 56% on Pfizer licensing deal

Voyager Therapeutics (VYGR) stock jumps 56% on Pfizer licensing deal

Highlights Voyager Therapeutics, Inc. (NASDAQ: VYGR) sealed a license option deal with Pfizer worth around US$630 million. Pfizer may exercise the option to use Voyager’s RNA-driven TRACERTM screening technology for developing its gene th...

Read More...
Ocugen (OCGN) & Aditxt (ADTX): Two trending biotech stocks

Ocugen (OCGN) & Aditxt (ADTX): Two trending biotech stocks

Highlights Ocugen, Inc. (NASDAQ: OCGN) has entered into a development and supply agreement with Bharat Biotech for a Covid-19 vaccine candidate. Aditxt, Inc. (NASDAQ: ADTX) has entered into a transaction agreement for acquiring a subsidiary of ...

Read More...
Xenon (XENE), OpGen (OPGN) stocks soar on drug results, FDA approval

Xenon (XENE), OpGen (OPGN) stocks soar on drug results, FDA approval

Highlights Xenon Pharmaceuticals Inc. (NASDAQ: XENE) achieved positive topline results from phase-2b clinical trials of‘XEN1101’ for treating focal epilepsy.  OpGen, Inc. (NASDAQ: OPGN) got 510(k) received FDA clearance to mark...

Read More...
ALZN & AEZS: Two trending biotechnology stocks on Friday

ALZN & AEZS: Two trending biotechnology stocks on Friday

Highlights Aeterna Zentaris Inc. (NASDAQ: AEZS) develops diagnostic and therapeutic tests. Alzamend Neuro, Inc. (NASDAQ: ALZN) develops treatment for neurodegenerative diseases and psychiatric disorders.  Aeterna has been placed on NASDAQ...

Read More...
Atea (AVIR) & Catalyst (CPRX): Two trending healthcare stocks today

Atea (AVIR) & Catalyst (CPRX): Two trending healthcare stocks today

Highlights Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) stocks surged 11.24 percent to US$35.74 on September 30. Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) jumped 7.97 percent to US$5.42 at 1.50 pm on Thursday. CPRX received a favorable court ...

Read More...